Drugs

Rulemaking History for OTC Hypophosphatemia/Hyperphosphatemia Drug Products

Final Monographs (21 CFR 310.541 & 310.542):
Over-the-counter (OTC) drug products containing active ingredients offered for use in the treatment of hypophosphosphatemia/hyperphosphosphatemia

FDA Archive-It webpage:

Search for Federal Register documents:

Hypophosphatemia/Hyperphosphatemia Drug Products

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice of Proposed Rulemaking12/9/198045FR81154
    Correction1/9/198146FR2365
Proposed RuleDateFR Citation
Proposed Rule: No GRASE ingredients & adds professional labeling for antacids1/15/198550FR2160
Final RuleDateFR Citation
Final Monograph: No GRASE ingredients & adds professional labeling for antacids5/11/199055FR19852

 

Page Last Updated: 12/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English